Public Profile

Kindeva Drug Delivery L.P.

Kindeva Drug Delivery L.P., a leading player in the pharmaceutical industry, is headquartered in the United States and operates across key regions globally. Founded in 2020, the company has quickly established itself as a pioneer in drug delivery solutions, focusing on innovative inhalation and transdermal technologies. Kindeva's core offerings include advanced drug delivery systems that enhance the efficacy and patient experience of medications. Their unique approach combines scientific expertise with cutting-edge technology, positioning them as a trusted partner for pharmaceutical companies. With a commitment to quality and innovation, Kindeva has achieved significant milestones, including collaborations with major industry players, solidifying its market position as a go-to provider for complex drug delivery challenges.

DitchCarbon Score

How does Kindeva Drug Delivery L.P.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

2

Industry Benchmark

Kindeva Drug Delivery L.P.'s score of 18 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.

84%

Kindeva Drug Delivery L.P.'s reported carbon emissions

Kindeva Drug Delivery L.P., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their current climate impact or commitments. However, the company is likely aware of the growing importance of sustainability in the pharmaceutical industry and may be exploring initiatives to address climate change. As the industry increasingly focuses on reducing carbon footprints, Kindeva's future commitments and actions will be crucial in aligning with global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Kindeva Drug Delivery L.P.'s primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Kindeva Drug Delivery L.P. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Kindeva Drug Delivery L.P. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Astra Zeneca

GB
Chemicals nec
Updated 1 day ago

Merck Sharp & Dohme LLC

US
Chemicals nec
Updated 4 days ago
DitchCarbon Score

Chiesi Ltd.

GB
Chemicals nec
Updated 4 days ago
DitchCarbon Score

Chiesi Farmaceutici

IT
Medical, precision and optical instruments, watches and clocks (33)
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers